RFT1 deficiency in three novel CDG patients

Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, François Foulquier, Hudson H. Freeze, Gert Matthijs, Thierry Hennet

Research output: Contribution to journalArticle


The medical significance of N-glycosylation is underlined by a group of inherited human disorders called Congenital Disorders of Glycosylation (CDG). One key step in the biosynthesis of the Glc 3Man 9Glc-NAc 2-PP-dolichol precursor, essential for N-glycosylation, is the translocation of Man 5GlcNAc 2-PP-dolichol across the endoplasmic reticulum membrane. This step is facilitated by the RFT1 protein. Recently, the first RFT1-deficient CDG (RFT1-CDG) patient was identified and presented a severe N-glycosylation disorder. In the present study, we describe three novel CDG patients with an RFT1 deficiency. The first patient was homozygous for the earlier reported RFT1 missense mutation (c.199C>T; p.R67C), whereas the two other patients were homozygous for the missense mutation c.454A>G (p.K152E) and c.892G>A (p.E298 K), respectively. The pathogenic character of the novel mutations was illustrated by the accumulation of Man 5GlcNAc 2-PP-dolichol and by reduced recombinant DNase 1 secretion. Both the glycosylation pattern and recombinant DNase 1 secretion could be normalized by expression of normal RFT1 cDNA in the patients' fibroblasts. The clinical phenotype of these patients comprised typical CDG symptoms in addition to sensorineural deafness, rarely reported in CDG patients. The identification of additional RFT1-deficient patients allowed to delineate the main clinical picture of RFT1-CDG and confirmed the crucial role of RFT1 in Man 5GlcNAc 2-PPdolichol translocation.

Original languageEnglish
Pages (from-to)1428-1434
Number of pages7
JournalHuman Mutation
Issue number10
Publication statusPublished - Oct 2009


  • CDG
  • Dolichol
  • Glycosylation
  • RFT1

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'RFT1 deficiency in three novel CDG patients'. Together they form a unique fingerprint.

  • Cite this

    Vleugels, W., Haeuptle, M. A., Ng, B. G., Michalski, J. C., Battini, R., Dionisi-Vici, C., Ludman, M. D., Jaeken, J., Foulquier, F., Freeze, H. H., Matthijs, G., & Hennet, T. (2009). RFT1 deficiency in three novel CDG patients. Human Mutation, 30(10), 1428-1434. https://doi.org/10.1002/humu.21085